Using host and bacterial genetic approaches to define virulence strategies and protective immunity during Mycobacterium tuberculosis infection
- PMID: 40261010
- PMCID: PMC12108062
- DOI: 10.1128/msphere.00517-24
Using host and bacterial genetic approaches to define virulence strategies and protective immunity during Mycobacterium tuberculosis infection
Abstract
Infections with Mycobacterium tuberculosis (Mtb) resulted in over one million deaths in 2024, the highest number for any infectious disease. With no vaccines that protect against pulmonary tuberculosis (TB) and the challenges associated with antibiotic therapy, there is a critical need to better understand host-Mtb interactions to help curb this major public health problem. Mtb is arguably the most successful human pathogen, and it survives in diverse environments, resulting in heterogeneous disease outcomes in patients. Five years ago, in my commentary in mSphere, I discussed how Mtb virulence strategies that sense, adapt, and evade killing in the host can be uncovered using genetic approaches. Here, I will come full circle to highlight genetic approaches that recently uncovered new mechanisms regulating protective host responses and Mtb survival tactics. The goal is to highlight a genetic framework to probe a range of unexplored Mtb phenotypes, increase our understanding of host-Mtb interactions, and identify new therapeutic targets that may help prevent TB.
Keywords: Mycobacterium; genetics; host-pathogen interactions; immune evasion.
Conflict of interest statement
The author declares no conflict of interest.
Figures

Similar articles
-
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.Semin Immunopathol. 2016 Mar;38(2):167-83. doi: 10.1007/s00281-015-0537-x. Epub 2015 Oct 28. Semin Immunopathol. 2016. PMID: 26510950 Free PMC article. Review.
-
Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence.Front Immunol. 2021 Jun 28;12:668060. doi: 10.3389/fimmu.2021.668060. eCollection 2021. Front Immunol. 2021. PMID: 34276658 Free PMC article.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.Tuberculosis (Edinb). 2018 Dec;113:200-214. doi: 10.1016/j.tube.2018.10.009. Epub 2018 Oct 30. Tuberculosis (Edinb). 2018. PMID: 30514504 Review.
-
Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.Semin Immunol. 2018 Oct;39:88-101. doi: 10.1016/j.smim.2018.07.001. Epub 2018 Jul 7. Semin Immunol. 2018. PMID: 30327124 Review.
References
-
- Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, Schuster BM, Trauner A, Wallis D, Galaviz S, Huttenhower C, Sacchettini JC, Behar SM, Rubin EJ. 2013. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 155:1296–1308. doi:10.1016/j.cell.2013.10.045 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical